LMAT vs QDEL: fair value comparison
LeMaitre Vascular, Inc. and QuidelOrtho Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, LMAT currently sits closer to the top of our discount ranking. LMAT carries the stronger quality grade.
| LMAT | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $81.08 | $13.75 |
| 12-month range | $79.54–$111.42 | $12.64–$31.25 |
| Sector rank | #23 of 113 Healthcare | #28 of 113 Healthcare |
| Quality grade | A | F |
| Leverage | Low | High |
| Margin trend | Expanding | Contracting |
| Revenue growth | Strong | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Downtrend |
| DCF cross-check | Undervalued | — |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: LMAT fair value analysis · QDEL fair value analysis